Revisiting viral reprogramming: Measles virus as a robust platform for high-quality iPSC generation
Molecular Therapy Advances · 2026-06 · 34 (2) · 201759
DOI: 10.1016/j.omta.2026.201759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-06. Verfasst von Mohamed Taha Moutaoufik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, UM6P Hospitals, Mohammed VI Polytechnic University, Ben Guerir, Morocco. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Muscular Dystrophy Canada, US Department of Defense.
Abstract (Originalsprache)
Induced pluripotent stem cells (iPSCs) have become a powerful tool for modeling human disease in vitro, particularly for investigating patient-specific genetic disorders. By reprogramming somatic cells into pluripotent cells and differentiating them into relevant lineages, such as cardiomyocytes, neurons, or skeletal muscle cells, it is possible to reproduce key cellular and functional disease phenotypes under controlled conditions.
Autor:innen und Institutionen
- Faculty of Medical Sciences, UM6P Hospitals, Mohammed VI Polytechnic University, Ben Guerir, Morocco.
- CERVO Brain Research Centre, Quebec City, QC, Canada.
- Department of Medicine, Faculty of Medicine, Laval University, Quebec City, QC, Canada.
Förderung
- Canadian Institutes of Health Research
- Muscular Dystrophy Canada
- US Department of Defense
Zitieren
APA
Moutaoufik, M. T., & Chahine, M. (2026). Revisiting viral reprogramming: Measles virus as a robust platform for high-quality iPSC generation. Molecular Therapy Advances, 34(2), 201759. https://doi.org/10.1016/j.omta.2026.201759
Vancouver
Moutaoufik MT, Chahine M. Revisiting viral reprogramming: Measles virus as a robust platform for high-quality iPSC generation. Molecular Therapy Advances. 2026;34(2):201759. doi:10.1016/j.omta.2026.201759
BibTeX
@article{Moutaoufik2026,
author = {Moutaoufik, Mohamed Taha and Chahine, Mohamed},
title = {Revisiting viral reprogramming: Measles virus as a robust platform for high-quality iPSC generation},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {2},
pages = {201759},
doi = {10.1016/j.omta.2026.201759}
}
EUVIMED